U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H33N2O2
Molecular Weight 273.4347
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of DIBUTOLINE

SMILES

CCCCN(CCCC)C(=O)OCC[N+](C)(C)CC

InChI

InChIKey=SDEXVKFYBBHUKN-UHFFFAOYSA-N
InChI=1S/C15H33N2O2/c1-6-9-11-16(12-10-7-2)15(18)19-14-13-17(4,5)8-3/h6-14H2,1-5H3/q+1

HIDE SMILES / InChI
DIBUTOLINE, an antispasmodic drug, produces paresis of smooth muscles innervated by the parasympathetic nervous system. Its effect on the smooth muscles, therefore, simulates that of paralysis of the oculomotor nerve, that is, paresis of the sphincter of the iris and the ciliary muscles. DIBUTOLINE has no effect on the ocular muscles innervated by the sympathetic nervous system.

Approval Year

PubMed

PubMed

TitleDatePubMed
Report of a preliminary clinical trial of dibutoline, a new antispasmotic drug.
1947 Feb
Further clinical observations on the use of dibutoline, a new antispasmodic drug.
1948 Aug
Clinical evaluation of dibutoline in diseases of the gastro-intestinal tract.
1948 Feb 15
Name Type Language
DIBUTOLINE
Common Name English
DIBUTOLINE ION
Common Name English
ETHANAMINIUM, 2-(((DIBUTYLAMINO)CARBONYL)OXY)-N-ETHYL-N,N-DIMETHYL-
Systematic Name English
DIBUTOLINE CATION
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID90176369
Created by admin on Fri Dec 15 15:03:58 GMT 2023 , Edited by admin on Fri Dec 15 15:03:58 GMT 2023
PRIMARY
PUBCHEM
10764
Created by admin on Fri Dec 15 15:03:58 GMT 2023 , Edited by admin on Fri Dec 15 15:03:58 GMT 2023
PRIMARY
CAS
21962-82-3
Created by admin on Fri Dec 15 15:03:58 GMT 2023 , Edited by admin on Fri Dec 15 15:03:58 GMT 2023
PRIMARY
FDA UNII
1B3Q705AQH
Created by admin on Fri Dec 15 15:03:58 GMT 2023 , Edited by admin on Fri Dec 15 15:03:58 GMT 2023
PRIMARY